Malik Navid's Form 4 filing
Northwest Biotherapeutics Inc (NWBO) · filed Dec 1, 2023
- Accession no.
- 0001104659-23-122940
- Filed
- Dec 1, 2023
- Trade date
- Nov 16-17, 2023
- Filing delay
- 15 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $469.9K. It was filed 15 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Malik NavidCIK 0001629113 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 | Common Stock | SSaleAcquired | +125,000 | $0.84 | +$105,000 | 445,000 | Direct | |
| Nov 17, 2023 | Common Stock | SSaleAcquired | +150,000 | $0.82 | +$123,000 | 295,000 | Direct | |
| Nov 17, 2023 | Common Stock | SSaleAcquired | +295,000 | $0.82 | +$241,900 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.